These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17116025)

  • 1. A long-term follow-up of zonisamide monotherapy.
    Fukushima K; Seino M
    Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
    Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
    Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of zonisamide in pediatric patients.
    Santos CC; Brotherton T
    Pediatr Neurol; 2005 Jul; 33(1):12-4. PubMed ID: 15876518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of zonisamide in refractory childhood-onset epilepsy.
    Kluger G; Zsoter A; Holthausen H
    Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
    You SJ; Kang HC; Kim HD; Lee HS; Ko TS
    Brain Dev; 2008 Apr; 30(4):287-90. PubMed ID: 17959327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.
    Park SP; Hwang YH; Lee HW; Suh CK; Kwon SH; Lee BI
    Epilepsy Behav; 2008 Jan; 12(1):102-8. PubMed ID: 17945539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide: physician and patient experiences.
    Marmarou A; Pellock JM
    Epilepsy Res; 2005; 64(1-2):63-9. PubMed ID: 15869867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability.
    Iinuma K; Minami T; Cho K; Kajii N; Tachi N
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():68-73. PubMed ID: 10030436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.